glp 1 and chronic kidney disease GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes Effects of Semaglutide on CKD

These symptoms are often more noticeable when starting the medication or increasing the dose (Reference)

Individuals who are overweight or have a Body Mass Index (BMI) of 30 or higher, indicating obesity People with health issues such as diabetes, high blood pressure, or high cholesterol Those who are in the process of weight loss and require additional support Individuals seeking to reduce unhealthy snacking habits People who have not seen results from other weight-loss methods, such as non-standard weight loss medications Anyone looking for a safe weight-loss solution with no side effects or risk of yo-yo weight gain Who Should Not Use the GLP-1

Driscoll AK et al

The most important thing to remember is that you shouldnt adjust your dosage, skip injections, or stop treatment without medical guidance

Patient characteristics affecting the tumor risk of GLP-1RAs Age and gender Meta-analyses have demonstrated that GLP-1RAs reduce the risk of prostate cancer, particularly in older male populations [115]

Would you prefer dealing with medication once a week or every day